Jim Simons

Jim Simons Renaissance Technologies

AUM $75.8B
1-Year Est. Return 50.56%
 

Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.

This Quarter Est. Return
1 Year Est. Return
+50.56%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$75.8B
AUM Growth
+$582M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
4,038
New
Increased
Reduced
Closed

Top Buys

1 +$633M
2 +$487M
3 +$419M
4
META icon
Meta Platforms (Facebook)
META
+$345M
5
KO icon
Coca-Cola
KO
+$257M

Top Sells

1 +$1.36B
2 +$900M
3 +$583M
4
NVDA icon
NVIDIA
NVDA
+$335M
5
NFLX icon
Netflix
NFLX
+$320M

Sector Composition

1 Technology 21.71%
2 Healthcare 15.16%
3 Consumer Discretionary 11.8%
4 Communication Services 10.53%
5 Financials 9.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DFAT icon
3101
Dimensional US Targeted Value ETF
DFAT
$12.4B
$227K ﹤0.01%
3,900
-18,900
GRO
3102
Brazil Potash Corp
GRO
$107M
$227K ﹤0.01%
84,325
+50,025
EBON icon
3103
Ebang International Holdings
EBON
$21.5M
$226K ﹤0.01%
50,113
+900
MCBS icon
3104
MetroCity Bankshares
MCBS
$828M
$224K ﹤0.01%
8,094
-10,155
ASPSZ
3105
Altisource Portfolio Solutions SA Cash Exercise Stakeholder Warrants
ASPSZ
$15.1M
$224K ﹤0.01%
386,322
-31,200
AHG
3106
Akso Health Group
AHG
$670M
$224K ﹤0.01%
129,198
-1,600
GANX icon
3107
Gain Therapeutics
GANX
$107M
$223K ﹤0.01%
126,100
+32,100
BCI icon
3108
abrdn Bloomberg All Commodity Strategy K-1 Free ETF
BCI
$2B
$222K ﹤0.01%
10,300
-49,000
SIFY
3109
Sify Technologies
SIFY
$845M
$221K ﹤0.01%
+16,200
PBBK icon
3110
PB Bankshares
PBBK
$53.5M
$221K ﹤0.01%
+11,500
RJET
3111
Republic Airways Holdings Inc. Common Stock
RJET
$920M
$218K ﹤0.01%
167,784
+67,584
CALC icon
3112
CalciMedica
CALC
$67.7M
$215K ﹤0.01%
70,000
+34,000
HIFS icon
3113
Hingham Institution for Saving
HIFS
$627M
$215K ﹤0.01%
816
-6,373
ATHA icon
3114
Athira Pharma
ATHA
$27.6M
$215K ﹤0.01%
51,924
+27,824
FMFC
3115
Kandal M Venture Ltd
FMFC
$5.82M
$215K ﹤0.01%
+14,600
BKV
3116
BKV Corp
BKV
$2.61B
$213K ﹤0.01%
9,200
-30,600
DRUG
3117
Bright Minds Biosciences
DRUG
$583M
$212K ﹤0.01%
+3,500
CRGO icon
3118
Freightos
CRGO
$149M
$211K ﹤0.01%
63,900
+18,000
CRDF icon
3119
Cardiff Oncology
CRDF
$171M
$210K ﹤0.01%
101,800
-27,890
XOM icon
3120
Exxon Mobil
XOM
$492B
$209K ﹤0.01%
1,865
-495,117
AWX icon
3121
Avalon Holdings
AWX
$10.2M
$209K ﹤0.01%
80,210
-3,775
SSKN icon
3122
Strata Skin Sciences
SSKN
$7.65M
$209K ﹤0.01%
101,530
+3,500
XENE icon
3123
Xenon Pharmaceuticals
XENE
$3.33B
$209K ﹤0.01%
5,200
-3,400
LNKB icon
3124
LINKBANCORP
LNKB
$318M
$208K ﹤0.01%
29,200
+10,800
BLTE
3125
Belite Bio
BLTE
$5.81B
$208K ﹤0.01%
2,812
-1,488